The FDA has formally warned a number of firms to stop their illegal sales of unapproved, mislabeled version of the acne drug, Accutane (isotretinoin).
The Weekly Roundup: April 22-26
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Optical Coherence Tomography in Preoperative Mapping of BCC: A Novel Approach to Optimizing Mohs Micrographic Surgery
ReV Up Your Vitiligo Treatment Strategies
QUIZ RECAP: Test Your Knowledge of Rosacea Treatment Modalities and the Therapeutic Landscape
Addressing Disparities in Skin-Aging Prevention Among Women of Color